ASR Vermogensbeheer’s United Therapeutics UTHR Stock Holding History

ASR Vermogensbeheer’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.71M	Sell	16,070 -2,977	-16%	-$1.54M	0.09%	211
2026 Q2	$10.3M	Buy	19,047 +17,826	+1,460%	+$10M	0.11%	187
2026 Q1	$724K	Buy	1,221 +29	+2%	+$14.4K	0.01%	457
2025 Q4	$581K	Sell	1,192 -15	-1%	-$6.98K	0.01%	470
2025 Q3	$506K	Sell	1,207 -14	-1%	-$4.71K	0.01%	483
2025 Q2	$351K	Sell	1,221 -6	-0.5%	-$1.79K	﹤0.01%	520
2025 Q1	$378K	Buy	+1,227	New	+$420K	0.01%	514

Other funds holding UTHR

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

ASR Vermogensbeheer's UTHR Position: Q3 2026 in Review

ASR Vermogensbeheer reduced its United Therapeutics (UTHR) stake by 16% in Q3 2026, selling an estimated $1.54M and leaving 16,070 shares worth $8.71M. The position accounts for 0.09% of the portfolio, ranked #211.

ASR Vermogensbeheer first reported a position in UTHR in Q1 2025 and has held it in 7 quarters since. The position peaked at $10.3M in Q2 2026. 549 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

ASR Vermogensbeheer held 16,070 shares of United Therapeutics worth $8.71M as of Q3 2026.
ASR Vermogensbeheer sold 2,977 United Therapeutics shares in Q3 2026, an estimated $1.54M.
United Therapeutics made up 0.09% of ASR Vermogensbeheer's portfolio in Q3 2026, its #211 holding.
ASR Vermogensbeheer first reported a position in United Therapeutics in Q1 2025 and has held it in 7 quarters since.
ASR Vermogensbeheer's United Therapeutics position peaked at $10.3M in Q2 2026.
549 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on ASR Vermogensbeheer's 13F filing for Q3 2026, filed 16 Oct 2026.